sameAs
Pancreatic cancerKras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreasIntraductal papillary mucinous neoplasms of the pancreas: an updated experiencePancreatic cancer genomes reveal aberrations in axon guidance pathway genesCore signaling pathways in human pancreatic cancers revealed by global genomic analysesInactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinomaDistant metastasis occurs late during the genetic evolution of pancreatic cancerMutant proteins as cancer-specific biomarkersRecent progress in pancreatic cancerAberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinomaPalladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cellsPrevalence of unsuspected pancreatic cysts on MDCTGenetic mutations associated with cigarette smoking in pancreatic cancerExomic sequencing identifies PALB2 as a pancreatic cancer susceptibility genePeriampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosisBRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targetsA neural survival factor is a candidate oncogene in breast cancerCurrent concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemSurgical and molecular pathology of pancreatic neoplasmsPancreatic adenocarcinoma pathology: changing "landscape"Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencingHuman correlates of provocative questions in pancreatic pathologyIn vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the PancreasExploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarraysAberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNsOncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisMutations in CIC and FUBP1 contribute to human oligodendrogliomaConcordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesionPD-1 Blockade in Tumors with Mismatch-Repair DeficiencyHuman Proteinpedia enables sharing of human protein dataBiomarker discovery from pancreatic cancer secretome using a differential proteomic approachHomozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapyDAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumorsA monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeysInhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancerExome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1
P50
Q24170403-9203B96A-F7B1-4E4B-BF0D-B2C7250275BAQ24299520-4A17EABF-B8A3-4630-A557-29F94866487DQ24540094-3BAAA159-B52B-4184-AFD1-17ACA9709CD9Q24595981-39D3A5B8-49C3-40F4-A4AF-61D10132EAC9Q24595981-D7F12F5D-E38C-4F76-B1A8-25B0BE64EA53Q24606006-075395F2-BD64-4325-A3D5-AB7DD400A93BQ24609544-A632D8B8-32B2-41A6-B63F-025A6533F562Q24624284-EB89C760-36E4-4AB6-9918-EEEA4DF48F6FQ24625180-2594DC43-15E3-4A38-BBFD-0B5FD0F8EAE3Q24626346-5C510D58-CA65-44F8-A158-A7F1ED3078C5Q24627680-0D9D7FE6-6734-4664-A2CF-D892AE47B7A9Q24628890-992E393B-EC83-4AFF-8922-B710A3C2CFA1Q24650018-7CD69F7F-6DDD-476B-B33F-27EBD4468E4CQ24658185-BB15DB95-E2BA-4BB2-9A13-E7852DA7386EQ24658271-091BAD2D-C549-43E2-AA57-8BAAEB998932Q24676143-AC8DEB01-3F1B-4D58-A569-8BB423340134Q24685106-807CC1A3-E55C-4F84-BA4F-B3AF91E58E9FQ24685777-209E13C8-7960-44D9-82ED-1674389ED693Q26748510-1BB29148-17BB-41D4-AE64-DFDF69553670Q26748615-567EA2C3-A4F3-4353-BF19-7C58CC95A1C2Q26799446-73649AF1-CD59-4276-A1A6-85B880862E9DQ26991615-382468E9-D4FE-4E1D-A83C-23F9735B1578Q27023576-855DA47B-0E98-4C23-83DC-19F770346B3CQ27824848-9FF22AB2-2A8A-4010-B281-9D8EA8083287Q27851466-16B42D94-D03B-42B8-A3EF-76DB15409D9BQ27851475-6EB52C3E-7185-4E52-BA46-C5DD75A17C6EQ27851614-671C12EF-DA40-49E5-9757-ADB5AD56879CQ28082890-070B2065-326D-4545-BF84-2F887891D4BEQ28185685-E03C9260-92AE-44CF-9226-34483885A31FQ28214865-55EE3AE9-8018-41FF-A2BA-F967271CEC09Q28242612-AE6714BF-111D-46C8-85E5-B1FE7B734662Q28244895-B97998C2-F219-4A2D-810F-E07B1297CD5DQ28245326-6A79BB49-B052-4B55-AD16-28B12713161DQ28262647-38896EF7-A084-4DD2-93C2-96FF88C0EB20Q28267923-2BB2DA90-2CA7-478F-8649-52DACCC5CF75Q28276398-CA47466E-DEA9-49C5-8994-32539379DEDDQ28303464-478AF10B-BC2D-4265-BABA-BCF0FAE71C3BQ28303693-DFB3DAD3-ED9A-4121-BD71-8EDDAA0C4CF7Q28728201-88EC6187-2A25-44A7-9E6F-FE25D7271AA1Q29547558-C49A67A6-7C0F-4B60-98B0-7BC25A71C6E6
P50
description
oncoloog
@nl
pathologist
@en
name
Ralph H. Hruban
@ast
Ralph H. Hruban
@en
Ralph H. Hruban
@es
Ralph H. Hruban
@nl
Ralph H. Hruban
@sl
type
label
Ralph H. Hruban
@ast
Ralph H. Hruban
@en
Ralph H. Hruban
@es
Ralph H. Hruban
@nl
Ralph H. Hruban
@sl
altLabel
Ralph H Hruban
@en
Ralph Hruban
@en
prefLabel
Ralph H. Hruban
@ast
Ralph H. Hruban
@en
Ralph H. Hruban
@es
Ralph H. Hruban
@nl
Ralph H. Hruban
@sl
P1006
P1015
P214
P244
P268
P269
P349
P1006
P1015
P1207
n2005024828
P1412
P21
P213
0000 0003 7455 6725